Indeed, miR-644a significantly sensitized p53-mut MDA-MB-231 and p53-wt MCF-7 cells to doxorubicin and BRCA1-mutated MDA-MB-436 breast cancer cells to cisplatin in vitro (Figure 3A, 3B and 3D). The gene discussed is TP53; the disease is breast carcinoma.